OFSA3
vs
B
BOVESPA
OFSA3
Over the past 12 months, OFSA3 has underperformed BOVESPA, delivering a return of +17% compared to the BOVESPA's +22% growth.
Stocks Performance
OFSA3 vs BOVESPA
Performance Gap
OFSA3 vs BOVESPA
Performance By Year
OFSA3 vs BOVESPA
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Ouro Fino Saude Animal Participacoes SA
Glance View
Ouro Fino Saúde Animal Participações SA engages in the development, production, and sale of veterinary drugs, vaccines, and other products for production and companion animals. The firm manufactures veterinary products using scientific technology in the Company's laboratories. The firm's products are divided into six sectors: Wholesale, Birds, Cattle, Equine, Pet and Pigs. The Wholesale area is divided into four lines: Anti-Mastiticos, producing antibiotics killing bacteria and lumps; Antimicrobial, which focuses on the treatment of bacterial infectious diseases; Ectoparasiticides, concentrated on insect repellent products, and Endectocides, which is the treatment and control of internal and external diseases of cattle, sheep and swine parasites. There is also one additional line of products divided for additives, biological, inoculants, diagnostic kit, probiotics, silage and other supplements, among others.